Yale Psychopharmacology Master Class: Focus on Depression


Yale Psychopharmacology Master Class: Focus on Depression Banner

Add to Calendar Yale Psychopharmacology Master Class: Focus on Depression 9/26/2025 7:00:00 AM 9/26/2025 3:30:00 PM America/New_York For More Details: https://yale.cloud-cme.com/Psychopharmacology2025 Description: The Yale Psychopharmacology Symposium provides a comprehensive review of recent advances in depression treatment. The program explores newly approved therapeutics—including esketamine, zuranolone, brexanolone, dextromethorphan/bupropion, and xanomeline/trospium—as well as the emergence of digital therapeutics and promising investigational treatments such as psilocybin, kappa opioid receptor antagonists, and KV7 ... Anthony's Ocean View false MM/DD/YYYY


Date & Location
Friday, September 26, 2025, 7:00 AM - 3:30 PM, Anthony's Ocean View, New Haven, CT

Target Audience
Specialties - Primary Care, Psychiatry, Psychology
Professions - Nurse, Physician, Social Worker, Student

Overview

The Yale Psychopharmacology Symposium provides a comprehensive review of recent advances in depression treatment. The program explores newly approved therapeutics—including esketamine, zuranolone, brexanolone, dextromethorphan/bupropion, and xanomeline/trospium—as well as the emergence of digital therapeutics and promising investigational treatments such as psilocybin, kappa opioid receptor antagonists, and KV7 ion channel modulators. Designed and led by experts from the Yale Depression Research Program, this one-day course equips providers and trainees with the latest developments, practice standards, and future innovations shaping the treatment of depression and related disorders.

 

Note: This educational program is designed to present scientific information and opinion for healthcare professionals, to stimulate thought, and further investigation.


Objectives
  1. Evaluate the efficacy, safety, and evidence-based algorithms for current pharmacological treatments and medical devices.
  2. Assess the role of psychopharmacological, brain stimulation, and psychosocial treatments in managing challenging clinical situations.
  3. Describe advancements in psychopharmacology and their potential impact on the treatment of serious mood disorders.
  4. Identify opportunities for innovation in clinical trials and future therapeutic developments in psychopharmacology.

Registration

  • Physicians - $300

  • Nurses/PAs/Allied Health Professionals - $225

  • Psychologists - $225

  • Social Workers - $150

  • Non- Yale Residents/Students/Fellows - $100

*All cancellations must be received in writing (via e-mail) at least one week prior to the start of the conference to receive a full refund. Any requests for refunds received after this date will not be honored.

Yale Medical Trainees Complimentary Registration Option – Verification Required

Limited to 20 total participants across all below eligible categories

Complimentary registration options are available only to current Yale medical trainees and students in the following categories:

  • Yale Residents/Fellows

  • Yale Medical Students

  • Yale Nursing Students

Verification Required:
A letter of verification from a department head must accompany your registration. A PDF copy should be emailed to [email protected] with the program name in the subject line.

If verification is not received within 3 weeks of registration, your spot will be released to allow other eligible participants to register.


Accreditation

The Yale School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Designation Statement
The Yale School of Medicine designates this enduring material for a maximum of 6.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure Policy
It is the policy of Yale School of Medicine, Continuing Medical Education (CME), to ensure balance, independence, objectivity, and scientific rigor in all its educational programs.  All individuals involved in the development and presentation of Accredited Continuing Education activities are required to disclose all financial relationship(s) with ineligible companies that has occurred within the past 24 months; and the opportunity to affect the content of CME about the products or services of the commercial interests. This information is disclosed to all activity participants prior to the commencement of the educational activity.


Credits
AMA PRA Category 1 Credits™ (6.50 hours), ABIM MOC Part 2 (6.50 hours), Non-Physician Attendance (6.50 hours)